Vema Hydrogen
Seed Round in 2025
Vema Hydrogen is a trailblazing company specializing in clean hydrogen production. It tackles the global challenge of decarbonization by generating hydrogen through geologic stimulation, offering a clean and cost-effective alternative to traditional methods. The company employs advanced numerical simulations, geochemical analysis, and multiphase flow studies to optimize hydrogen production. It also identifies and tests suitable geological locations for pilot projects, obtains necessary permits, and optimizes catalyst use to enhance efficiency.
Dunia Innovations
Venture Round in 2024
Dunia Innovations is pioneering the development of the world's first self-driving laboratory dedicated to electrocatalytic CO2 utilization. The company aims to facilitate the energy transition by addressing challenges in scalable carbon utilization, thereby fostering a circular carbon economy. By transforming carbon dioxide into valuable chemicals and fuels, Dunia Innovations helps businesses understand their carbon footprints and actively contributes to achieving net zero emissions. Through its innovative approach, the company seeks to significantly accelerate catalyst research and optimize processes for effective carbon management.
Turnover Labs
Pre Seed Round in 2024
Turnover Labs is a company focused on decarbonizing the chemical production industry by providing carbon-neutral alternatives to traditional petrochemicals. It specializes in producing industrial chemicals through innovative processes that utilize advanced electrocatalysts. These electrocatalysts enable the direct conversion of impure carbon dioxide waste from manufacturing facilities into valuable chemical building blocks on-site. This approach not only addresses environmental concerns but also improves operational efficiency by mitigating the challenges posed by harsh impurities, leading to longer device lifetimes and reduced purification costs. Ultimately, Turnover Labs aims to transform the way petrochemicals are generated, contributing to a more sustainable future for the chemical industry.
Clearly.Earth
Seed Round in 2024
AI driven SaaS platform for smarter mobility emission management for fleet owners, operators and customers.
Neurable
Venture Round in 2024
Neurable Inc. is a neurotechnology company based in Cambridge, Massachusetts, established in 2016. The company specializes in developing artificial intelligence software that allows users to control software and devices using their brain activity. By leveraging patented signal processing techniques and a multidisciplinary approach that combines neuroscience, biology, statistics, and machine learning, Neurable creates high-performance brain-computer interfaces. These interfaces enable users to interact with various applications, such as playing games, operating toys, and even driving vehicles, through their brain signals. Neurable's technology is also applicable in virtual and augmented reality environments, offering innovative solutions for enhancing user experience and interaction.
Virtonomy
Venture Round in 2023
Virtonomy GmbH is a Munich-based company that specializes in providing clinical trial services using virtual human, sheep, pig, and calf models. Founded in 2019, Virtonomy offers a platform that integrates digital twin models, AI, multi-physics simulations, and predictive analytics to enhance the development and evaluation of medical devices. The company delivers services such as anatomy studies, virtual fittings, pre-operative planning, and visualization through detailed image analysis and three-dimensional anatomical models. By enabling medical device manufacturers to optimize designs, reduce risks associated with anatomical variability, and develop patient-specific implants, Virtonomy facilitates a streamlined product development process. This approach not only shortens development timelines but also minimizes costs and risks linked to traditional clinical trials, allowing for safer and more efficient testing in a virtual environment.
Aerones is an innovative company founded in 2015 and headquartered in San Jose, California, that specializes in robotic technology for wind turbine blade maintenance. The company offers a range of automated services, including blade cleaning, de-icing, coating application, detailed inspections, data analysis, conductivity testing, and drainage hole cleaning and repair. Its robotic systems are designed to be compact and transportable, allowing for remote control and enhancing efficiency, speed, cost-effectiveness, and safety in the maintenance of wind turbines. Aerones aims to support the wind energy sector by streamlining maintenance processes and improving operational reliability.
Aerones
Seed Round in 2022
Aerones is an innovative company founded in 2015 and headquartered in San Jose, California, that specializes in robotic technology for wind turbine blade maintenance. The company offers a range of automated services, including blade cleaning, de-icing, coating application, detailed inspections, data analysis, conductivity testing, and drainage hole cleaning and repair. Its robotic systems are designed to be compact and transportable, allowing for remote control and enhancing efficiency, speed, cost-effectiveness, and safety in the maintenance of wind turbines. Aerones aims to support the wind energy sector by streamlining maintenance processes and improving operational reliability.
Celeris Therapeutics
Seed Round in 2022
Celeris Therapeutics is an AI-first drug discovery company that focuses on developing proximity-inducing compounds (PICs), particularly PIC degraders, to address high unmet medical needs in diseases like Parkinson's and various cancers. The company has created the Celeris One platform, which utilizes structure-based geometric deep learning to enhance the design and development of degraders by prioritizing specific E3 ligases, designing effective linkers, and selecting optimal compounds for synthesis. Additionally, Celeris Therapeutics operates an in-house automated laboratory that facilitates rapid generation of experimental data for further optimization. The company collaborates with pharmaceutical and biotech firms to discover and develop small-molecule degrader therapies across multiple therapeutic areas, while also advancing its own internal drug pipeline. Celeris Therapeutics maintains offices in Menlo Park, California, and Graz, Austria.